Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Doripenem - Shionogi

Drug Profile

Doripenem - Shionogi

Alternative Names: Doribax; Doripenem hydrate; Finibax IV Solution; S-4661

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shionogi
  • Developer Janssen Research & Development; Ortho-McNeil; Shionogi
  • Class Anti-infectives; Antibacterials; Carbapenems; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Gram-negative infections; Gram-positive infections; Intra-abdominal infections; Meningococcal infections; Nosocomial pneumonia; Paediatric infections; Respiratory tract infections; Urinary tract infections
  • Discontinued Bacterial infections; Pneumonia

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 12 Aug 2013 Discontinued - Phase-III for Nosocomial pneumonia in Australia, Canada, Guatemala, India, Israel, Mexico, Philippines, Russia, South Africa,Thailand, Turkey and Ukraine (IV)
  • 31 Jul 2013 Phase-III clinical trials in Intra-abdominal infections (in children and adolescents, Complicated) in India prior to July 2013 (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top